Investigation into the use of colestyramine as a therapy for patients with erythropoietic protoporphyria - EPP001
- Conditions
- Erythropoietic protoporphyria (EPP)MedDRA version: 9.1Level: LLTClassification code 10015289Term: Erythropoietic protoporphyria
- Registration Number
- EUCTR2007-002863-28-GB
- Lead Sponsor
- Guy's & St Thomas' NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 21
Patients who regularly attend the Photodermatoses clinic at St Thomas’ Hospital and meet the inclusion criteria below will be invited to participate in this trial: -
•Patients with a diagnosis of EPP.
•Patients aged 18 years or over.
•Patients who are willing and able to give written informed consent to participate in the trial.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years)
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
•Patients under 18 years of age
•Patients who do not adequately understand verbal explanations or written information given in English, or who have special communication needs and unable to give informed consent.
•Patients who are pregnant or breast feeding.
•Patients who are unwilling or unable to comply with the study protocol
•Patients with complete biliary obstruction
•Patients who have diabetes mellitus
•Patients with epilepsy
•Patients prescribed thyroxine sodium for hypothyroidism
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.